Results 221 to 230 of about 93,748 (310)

Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double‐blind, multicentre, therapeutic confirmatory phase 3 clinical trial

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim This study evaluated the efficacy and safety of empagliflozin 10 and 25 mg compared to placebo as add‐on treatment for people with type 2 diabetes mellitus (T2DM) uncontrolled after ≥8 weeks of treatment with metformin and sitagliptin. Materials and Methods A randomised, double‐blind, multicentre, therapeutic confirmatory, phase 3 clinical
Seung‐Hwan Lee, Kyung Ah Han, Eun‐Gyoung Hong, Jun Goo Kang, Choon Hee Chung, Jong Chul Won, Eon Ju Jeon, Jung‐Hwan Cho, Ho Chan Cho, Sin Gon Kim, Eun Seok Kang, So Hun Kim, Hae Jin Kim, In‐Kyung Jeong, Sung Wan Chun, Young Min Cho   +15 more
wiley   +1 more source

A Case of Moyamoya Disease With Spontaneous Regression of Posterior Choroidal Artery Aneurysm After Improvement in Obesity and Administration of an Antihypertensive Drug. [PDF]

Cureus
Hashiguchi A, Tonegawa T, Tashima K, Mizukami S, Moroki K.   +4 more
europepmc   +1 more source

Ultrasound and MRI abdominal fat distribution and its associations with metabolic conditions in adults with abdominal obesity

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To evaluate the accuracy of abdominal fat distribution of subcutaneous (SAT) and visceral adipose tissue (VAT) assessed by ultrasound (US) compared to magnetic resonance imaging (MRI), as the gold standard technique. Additionally, to assess the association between abdominal fat distribution measured by US and metabolic conditions in ...
Claudia Jiménez‐ten Hoevel, Maria Besora‐Moreno, Judit Queral, Elisabet Llauradó, Rosa M. Valls, Rosa Solà, Anna Pedret   +6 more
wiley   +1 more source

Antihypertensive drug-associated adverse events in osteoarthritis: a study of a large real-world sample based on the FAERS database. [PDF]

Front Pharmacol
Guo Z, Di J, Zhang Z, Chen S, Mao X, Wang Z, Yan Z, Li X, Tian Z, Mu C, Xiang C, Xiang C.   +11 more
europepmc   +1 more source

EFFICACY EVALUATION OF THE TRANSITION TO FIXED COMBINATION DRUG PRESTANCE IN PATIENTS WITH INSUFFICIENT CONTROL OF BLOOD PRESSURE BY OTHER ANTIHYPERTENSIVE MEDICATIONS OR COMBINATIONS: REGIONAL PROGRAM OBJECTIVE

, 2018
A. Ya. Kravchenko, Zarema Alimkhanova
openalex   +2 more sources

Cardiovascular biomarkers and preeclampsia: A narrative review

European Journal of Clinical Investigation, EarlyView.
Preeclampsia (PE) is a complex pregnancy disorder linked to cardiovascular disease (CVD) through shared risk factors and epidemiological associations. Cardiovascular biomarkers are valuable for predicting, diagnosing and assessing PE, as well as estimating future CVD risk. This review explores current cardiovascular biomarkers used in clinical practice
Johana Ullmo, Madalina Nicoleta Nan, Mónica Cruz‐Lemini, Carmen Garrido‐Gimenez, Judit Platero, Álvaro García‐Osuna, Pablo García‐Manau, Marcel Twickler, Elisa Llurba   +8 more
wiley   +1 more source

The trends of antihypertensive drug prescription based on the Japanese national data throughout the COVID-19 pandemic period. [PDF]

Hypertens Res
Natsume S, Satoh M, Murakami T, Sasaki M, Metoki H.   +4 more
europepmc   +1 more source

HDL function and composition in atherothrombotic cardiovascular disease with very high HDL‐C

European Journal of Clinical Investigation, EarlyView.
We investigated 49 individuals (mean age: 62 ± 2 years, 83% female) with very high HDL‐C (>80 mg/dL), including 23 with ASCVD. Despite matched HDL‐C levels, functional and compositional HDL features differed between groups. CEC differences became evident only after tertile stratification, with ASCVD participants overrepresented in the lowest tertile ...
Teresa Padro, Natàlia Muñoz‐García, Marta Fanlo‐Maresma, Virginia Esteve‐Luque, Paula Cabré‐Fernandez, Gemma Vilahur, Antoni Riera‐Mestre, Lina Badimon, Xavier Pintó   +8 more
wiley   +1 more source

Antihypertensive Drug Treatment and the Risk for Intrahemodialysis Hypotension.

Clin J Am Soc Nephrol
Zoccali C, Tripepi G, Carioni P, Fu EL, Dekker F, Stel V, Jager KJ, Mallamaci F, Hymes JL, Hymes JL, Maddux FW, Stuard S.   +11 more
europepmc   +1 more source

Association of Antihypertensive Drug-Related Gene Polymorphisms with Stroke in the Chinese Hypertensive Population. [PDF]

Int J Hypertens
Liu H, Zhong H, Lin Y, Han L, Chen M, Tang T, Deng J.   +6 more
europepmc   +1 more source